Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management (Q47988514)

7 February 2018

http://europepmc.org/abstract/MED/28779299

title

Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management (English)

1 reference

7 February 2018

http://europepmc.org/abstract/MED/28779299

author

Enno Schmidt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779299%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Kyle T Amber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779299%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Dedee F Murrell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779299%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Pascal Joly

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779299%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Luca Borradori

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779299%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

4 August 2017

1 reference

7 February 2018

http://europepmc.org/abstract/MED/28779299

published in

Clinical Reviews in Allergy & Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779299%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779299%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779299%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

26-51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779299%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Incidence and mortality of bullous pemphigoid in north-east Poland (Podlaskie Province), 1999-2012: a retrospective bicentric cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Mortality rate in bullous pemphigoid: a retrospective monocentric cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Mortality from acquired bullous diseases of skin in Canadian adults 2000-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Mortality of bullous pemphigoid in Switzerland: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Infectious complications in bullous pemphigoid: an analysis of risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Specific causes of death in patients with bullous pemphigoid as measured by death certificate data: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

The incidence of herpes zoster in cutaneous lupus erythematosus (CLE), dermatomyositis (DM), pemphigus vulgaris (PV), and bullous pemphigoid (BP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Role of MHC Class II genes in the pathogenesis of pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

The association of HLA-DQ7 with bullous pemphigoid is restricted to men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Gene map of the extended human MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Association of Bullous Pemphigoid and Malignant Neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Vesiculobullous eruption in a patient receiving psoralen ultraviolet A (PUVA) treatment for prurigo nodules: a case of PUVA-aggravated pemphigoid nodularis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Bullous pemphigoid: from the clinic to the bench.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Vesicular pemphigoid in a 16-year-old boy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Lichen planus pemphigoides: four new cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Childhood lichen planus pemphigoides: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Lichenoid erythrodermic bullous pemphigoid of the African patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Pemphigoid vegetans: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

21 January 2018

Seborrheic pemphigoid.

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

21 January 2018

Seborrheic pemphigoid

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Extensive erosive bullous pemphigoid: an atypical and serious clinical variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Purpuric bullous pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Bullous pemphigoid in infants: characteristics, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Bullous pemphigoid and neurodegenerative diseases: a study in a setting of a Central European university dermatology department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Localized bullous pemphigoid at urostomy site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Relationship between radiation therapy and bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Childhood bullous pemphigoid: a clinicopathologic study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Neurological disorders in patients with bullous pemphigoid: clinical and experimental investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Bullous pemphigoid and internal diseases - A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish Care Register study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

A population-based study of the association between bullous pemphigoid and neurologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Bullous pemphigoid and neurological disease: statistics from a dermatology service

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Neurological diseases and bullous pemphigoid: A case-control study in Iranian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Impact of neurological diseases on the prognosis of bullous pemphigoid: A retrospective study of 178 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Collagen XVII is expressed in human CNS neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Collagen XVII and BPAG1 expression in the retina: evidence for an anchoring complex in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Distribution of collagen XVII in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Autoantibodies to Collagen XVII Are Present in Parkinson's Disease and Localize to Tyrosine-Hydroxylase Positive Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Class II HLA interactions modulate genetic risk for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Molecular analysis of HLA class II-associated susceptibility to neuroinflammatory diseases in Korean children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Quality of life, depression, anxiety and loneliness in patients with bullous pemphigoid. A case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

The associations between bullous pemphigoid and drug use: a UK case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

The association between drugs and bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

A case report of bullous pemphigoid associated with a melanoma and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Bullous pemphigoid induced by PUVA therapy. Is this the aetiology of the acral bullae produced during PUVA treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

PUVA-induced lichen planus pemphigoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Increased risk of pemphigoid following scabies: a population-based matched-cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Bullous pemphigoid in infancy: Clinical and epidemiologic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Infantile Bullous Pemphigoid Treated Using Intravenous Immunoglobulin: Case Report and Review of the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Omalizumab therapy for bullous pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Bullous pemphigoid successfully treated with omalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Evidence for a role of eosinophils in blister formation in bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Herpes gestationis: Clinical and histologic features of twenty-eight cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Pemphigoid gestationis: current insights into pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Class II MHC typing in pemphigoid gestationis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Clinical features and management of 87 patients with pemphigoid gestationis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Retrospective analysis of pemphigoid gestationis in 32 Saudi patients - Clinicopathological features and a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Safety of topical corticosteroids in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Antepartum intravenous immunoglobulin therapy in refractory pemphigoid gestationis: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Pemphigoid gestationis: a successful preventive treatment by rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Pregnancy outcomes after maternal exposure to rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Anti-laminin gamma-1 pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

A subepidermal bullous eruption associated with IgG autoantibodies to a 200 kd dermal antigen: the first case report from the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Clinical and immunological features and outcome of anti-p200 pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Immunoglobulin G deposition to nonhemidesmosomal lamina lucida and early neutrophil involvement are characteristic features in a case of anti-p200 pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Pathogenicity of autoantibodies in anti-p200 pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

21 January 2018

IgA anti-p200 pemphigoid

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

A severe and refractory case of anti-p200 pemphigoid resulting in multiple skin ulcers and scar formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid--how to treat it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Anti-laminin γ1 pemphigoid accompanied by autoantibodies to laminin α3 and γ2 subunits of laminin-332.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Histopathology of anti-p200 pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

An attempt to develop mouse model for anti-laminin γ1 pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Ex vivo pathogenicity of anti-laminin γ1 autoantibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

A successful treatment with ustekinumab in a case of antilaminin-γ1 pemphigoid associated with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Refractory anti-laminin γ1 pemphigoid with psoriasis vulgaris successfully treated by double-filtration plasmapheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Autoimmune blistering diseases in females: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Clinical features and diagnosis of epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

The diagnosis and treatment of autoimmune blistering skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Quality-of-life measurement in blistering diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

The n- vs. u-serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Sensitivity of different assays for the serological diagnosis of epidermolysis bullosa acquisita: analysis of a cohort of 24 Italian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Epidermolysis bullosa acquisita: ultrastructural and immunological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Pemphigoid diseases: pathogenesis, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Management of epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Rituximab in treatment-resistant autoimmune blistering skin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Rituximab and its use in autoimmune bullous disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

The use of intravenous immunoglobulin in autoimmune bullous diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Immunoadsorption in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

HLA-DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Anti-epiligrin cicatricial pemphigoid and relative risk for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

A case of anti-epiligrin cicatricial pemphigoid associated with lung carcinoma and severe laryngeal stenosis: review of Japanese cases and evaluation of risk for internal malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Cicatricial pemphigoid: treatment with mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Rituximab for patients with refractory mucous membrane pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Biopsy location for direct immunofluorescence in patients with suspected bullous pemphigoid impacts probability of a positive test result

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Diagnostic value of immunohistochemistry on formalin-fixed, paraffin-embedded skin biopsy specimens for bullous pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

A Cross-sectional Study of Direct Immunofluorescence in the Diagnosis of Immunobullous Dermatoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Value of routine diagnostic criteria of bullous pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Role of direct immunofluorescence in dermatological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Direct and indirect immunofluorescence for the diagnosis of bullous autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Molecular diagnosis in autoimmune skin blistering conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Pemphigoid gestationis: Toward a better understanding of the etiopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Development of an ELISA for the detection of autoantibodies to BP230.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Evaluation of ELISA testing for BP180 and BP230 as a diagnostic modality for bullous pemphigoid: a clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Positive Direct Immunofluorescence Is of Better Value than ELISA-BP180 and ELISA-BP230 Values for the Prediction of Relapse after Treatment Cessation in Bullous Pemphigoid: A Retrospective Study of 97 Patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Usefulness of Enzyme-linked Immunosorbent Assay Using Recombinant BP180 and BP230 for Serodiagnosis and Monitoring Disease Activity of Bullous Pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Mucosal-dominant pemphigus vulgaris in a captopril-taking woman with angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin-332 IgG with oropharyngeal involvement and the usefulness of ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Low sensitivity of type VII collagen enzyme-linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Modern diagnosis of autoimmune blistering skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Diagnosis of oral mucous membrane pemphigoid by means of combined serologic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Application of confocal laser scanning microscopy to differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

The Relationship between Neurological Disease and Bullous Pemphigoid: A Population-Based Case–Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Mortality of patients with bullous pemphigoid in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

Anti-Skin Specific Autoantibodies Detected by a New Immunofluorescence Multiplex Biochip Method in Patients with Autoimmune Bullous Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-017-8633-4

21 January 2018

1 reference

12 December 2020

Localized bullous pemphigoid in a patient with B-cell lymphoma

1 reference

12 December 2020

Bullous pemphigoid induced by radiotherapy recurring on rechallenge

1 reference

12 December 2020

Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies

1 reference

12 December 2020

Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol

1 reference

12 December 2020

Childhood localized vulvar pemphigoid is a true variant of bullous pemphigoid

1 reference

12 December 2020

Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid

1 reference

12 December 2020

Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women

1 reference

12 December 2020

Antibasement membrane zone antibodies in localized pretibial pemphigoid

1 reference

12 December 2020

Bullous pemphigoid presenting as exfoliative erythroderma

1 reference

12 December 2020

Tetracycline and nicotinamide for the treatment of bullous pemphigoid: our experience in Singapore.

1 reference

12 December 2020

Serum autoantibodies against the dermal-epidermal junction in patients with chronic pruritic disorders, elderly individuals and blood donors prospectively recruited

1 reference

12 December 2020

Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid

1 reference

12 December 2020

Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping

1 reference

12 December 2020

HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain)

1 reference

12 December 2020

Pemphigoid gestationis

1 reference

12 December 2020

Pemphigoid and malignancy

1 reference

12 December 2020

Pemphigoid vegetans represents a bullous pemphigoid variant. Patient's IgG autoantibodies identify the major bullous pemphigoid antigen

1 reference

12 December 2020

The vesicular pemphigoid phenotype may be related to antibodies to a 200 kDa antigen in the lower lamina lucida

1 reference

12 December 2020

A case of epidermolysis bullosa acquisita with autoantibody to anti-p200 pemphigoid antigen and exfoliative esophagitis

1 reference

12 December 2020

Localized pretibial pemphigoid and pemphigoid nodularis

1 reference

12 December 2020

A long-term study of a patient with anti-p200 pemphigoid: correlation of autoantibody levels with disease activity and an example of epitope spreading

1 reference

12 December 2020

The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators

1 reference

12 December 2020

Bullous pemphigoid possibly induced by psoralen plus ultraviolet A therapy.

1 reference

12 December 2020

Immunoadsorber for specific apheresis of autoantibodies in the treatment of bullous pemphigoid

1 reference

12 December 2020

Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita

1 reference

12 December 2020

Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and its effects on soluble CD200

1 reference

12 December 2020

The autoantigen in anti-p200 pemphigoid is synthesized by keratinocytes and fibroblasts and is distinct from nidogen-2

1 reference

12 December 2020

Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production

1 reference

12 December 2020

Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated

1 reference

12 December 2020

The use of biochip immunofluorescence microscopy for the diagnosis of Pemphigus vulgaris

1 reference

12 December 2020

Unilateral bullous pemphigoid in a hemiplegic pagtient

1 reference

12 December 2020

Stump pemphigoid: a new complication of the amputee

1 reference

12 December 2020

Form and function: the laminin family of heterotrimers

1 reference

12 December 2020

A refractory, cutaneous, subepidermal bullous disease

1 reference

12 December 2020

Metastatic ovarian carcinoma-associated subepidermal blistering disease with autoantibodies to both the p200 dermal antigen and the gamma 2 subunit of laminin 5 showing unusual clinical features

1 reference

12 December 2020

Unilateral bullous pemphigoid without erythema and eosinophil infiltration in a hemiplegic patient

1 reference

12 December 2020

Erythrodermic bullous pemphigoid is a clinical variant of bullous pemphigoid

1 reference

12 December 2020

The association of bullous pemphigoid and malignant disease: a case control study

1 reference

12 December 2020

Treatment of bullous pemphigoid with rituximab: critical analysis of the current literature

1 reference

12 December 2020

Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses

1 reference

12 December 2020

Treatment of generalized bullous pemphigoid with oral tetracycline

1 reference

12 December 2020

Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group

1 reference

12 December 2020

Clinical variations in bullous pemphigoid with respect to early symptoms

1 reference

12 December 2020

Neurological disorders in patients with bullous pemphigoid

1 reference

12 December 2020

Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure

1 reference

12 December 2020

Long-term results of therapy with mycophenolate mofetil in ocular mucous membrane pemphigoid

1 reference

12 December 2020

Significantly increased occurrence of HLA-DQB1*0301 allele in patients with ocular cicatricial pemphigoid

1 reference

12 December 2020

Incidence and Mortality of Bullous Pemphigoid in France

1 reference

12 December 2020

Pemphigoid and cancer

1 reference

12 December 2020

Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany

1 reference

12 December 2020

Vesicular pemphigoid--ultrastructural and immunoelectron microscopic study.

1 reference

12 December 2020

U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases

1 reference

12 December 2020

Sepsis associated with dermatologic hospitalization is not the cause of high mortality of bullous pemphigoid in Europe

1 reference

12 December 2020

S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid.

1 reference

12 December 2020

Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group

1 reference

12 December 2020

Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report

1 reference

12 December 2020

Toward a practical renaming of bullous pemphigoid and all its variants: cutaneous pemphigoid

1 reference

12 December 2020

IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses

1 reference

12 December 2020

Childhood vulval pemphigoid: a clinical and immunopathological study of five patients

1 reference

12 December 2020

Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA).

1 reference

12 December 2020

Anti-epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: differentiation by use of indirect immunofluorescence microscopy

1 reference

12 December 2020

Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study

1 reference

12 December 2020

Bullous pemphigoid and dermatitis herpetiformis: mixed bullous disease or coexistence of two separate entities?

1 reference

12 December 2020

First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid

1 reference

12 December 2020

Malignancies in pemphigus and pemphigoid diseases

1 reference

12 December 2020

The value of BP230 enzyme-linked immunosorbent assay in the diagnosis and immunological follow-up of bullous pemphigoid

1 reference

12 December 2020

Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide

1 reference

12 December 2020

Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid

1 reference

12 December 2020

A case of anti-p200 pemphigoid: evidence for a different pathway in neutrophil recruitment compared with bullous pemphigoid

1 reference

12 December 2020

Bullous pemphigoid with localized umbilical involvement

1 reference

12 December 2020

Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients

1 reference

12 December 2020

Associations between bullous pemphigoid and primary malignant cancers: an English national record linkage study, 1999-2011

1 reference

12 December 2020

Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid

1 reference

12 December 2020

Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen

1 reference

12 December 2020

Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid?

1 reference

12 December 2020

Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab

1 reference

12 December 2020

Clues to the aetiology and pathogenesis of herpes gestationis

1 reference

12 December 2020

Vesicular pemphigoid vs dermatitis herpetifomis

1 reference

12 December 2020

Clinical features and practical diagnosis of bullous pemphigoid

1 reference

12 December 2020

Conversion of pemphigoid gestationis to bullous pemphigoid--two refractory cases highlighting this association

1 reference

12 December 2020

Treatment of bullous pemphigoid with adjuvant immunoadsorption: a case series

1 reference

12 December 2020

Unilateral bullous pemphigoid in a hemiplegic patient

1 reference

12 December 2020

S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid.

1 reference

12 December 2020

Refractory antilaminin γ1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetil

1 reference

12 December 2020

Acquired subepidermal bullous diseases associated with psoriasis: a clinical, immunopathological and immunogenetic study

1 reference

12 December 2020

Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients

1 reference

12 December 2020

Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations

1 reference

12 December 2020

Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany

1 reference

12 December 2020

Drugs associated with bullous pemphigoid. A case-control study

1 reference

12 December 2020

Clinical and immunological profiles of 25 patients with pemphigoid gestationis

1 reference

12 December 2020

An unusual case of localised pemphigoid

1 reference

12 December 2020

Localized bullous pemphigoid. A mimic of acute contact dermatitis

1 reference

12 December 2020

Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita

1 reference

12 December 2020

Bullous pemphigoid successfully controlled by tetracycline and nicotinamide

1 reference

12 December 2020

Bullous pemphigoid induced by topical PUVASOL

1 reference

12 December 2020

Identification of the Skin Basement-Membrane Autoantigen in Epidermolysis Bullosa Acquisita

1 reference

12 December 2020

Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita

1 reference

12 December 2020

1 reference

12 December 2020

The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan

1 reference

12 December 2020

Autoantibodies in anti-p200 pemphigoid stain skin lacking laminin 5 and type VII collagen

1 reference

12 December 2020

Anti-p200 pemphigoid: diagnosis and treatment of a case presenting as an inflammatory subepidermal blistering disease

1 reference

12 December 2020

Localized pemphigoid (pretibial type) with IgG antibody to BP180 NC16a domain successfully treated with minocycline and topical corticosteroid

1 reference

12 December 2020

[Seborrheic pemphigoid. A new nosologic entity?]

1 reference

12 December 2020

A routine immuno-electron microscopic technique for localizing an auto-antibody on epidermal basement membrane

1 reference

12 December 2020

A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone

1 reference

12 December 2020

Risk factors for bullous pemphigoid in the elderly: a prospective case-control study

1 reference

12 December 2020

The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid

1 reference

12 December 2020

Accuracy of indirect immunofluorescence on sodium chloride-split skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita

1 reference

12 December 2020

Bullous pemphigoid in a patient with psoriasis during the course of PUVA therapy: study by ELISA test

1 reference

12 December 2020

1 reference

12 December 2020

Erythrodermic bullous pemphigoid or erythrodermic psoriasis and bullous pemphigoid?

1 reference

12 December 2020

Infection in autoimmune bullous diseases: a retrospective comparative study

1 reference

12 December 2020

Anti-p200 pemphigoid in a 17-year-old girl successfully treated with systemic corticosteroid and dapsone

1 reference

12 December 2020

Nicotinamide and tetracycline therapy of bullous pemphigoid.

1 reference

12 December 2020

A case of concurrent antilaminin γ1 pemphigoid and antilaminin-332-type mucous membrane pemphigoid

1 reference

12 December 2020

Parkinson disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction

1 reference

12 December 2020

10.1007/S12016-017-8633-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779299%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference